Hematology

For information on the following Clinical Trials, please contact the
Hematology, Oncology and Stem Cell Transplantation Department
at 773-880-4562 during 8:30 AM to 5:00 PM Central Standard Time.

  Hemophilia Investigator
1 Controlled Trial of Immune-Tolerance Induction (ITI) Geoffrey Allen, MD
2 Factor XIII Fibrogammin P  Geoffrey Allen, MD 
3 Genetics of Inhibitor in Siblings with Hmophilia   Geoffrey Allen, MD 
4 Recombinant Human Factor IX (rFIX) for Treatment of Hemophilia B Geoffrey Allen, MD
5 Universal Data Collection (UDC)  Geoffrey Allen, MD
6  Hemophilia and Thrombosis Research Society Registry (HTRS) Geoffrey Allen, MD
7 Hemophilic Genotype, Inhibitors and Response to Immune Tolerance Geoffrey Allen, MD
8 Previously Untreated Hemophilia Patients-ADVATE Alexis Thompson, MD
9 Risk Factors for Inhibitor Development in Mild or Moderate Hemophilia A Geoffrey Allen, MD
10 Haemocomplettan P Geoffrey Allen, MD
11 Response to DDAVP in Children with Type 1 Von Willebrand Disease Using the PFA-100 Geoffrey Allen, MD
   

Sickle Cell

 Investigator
12 Novartis 2411 Registry Trial Alexis Thompson, MD
13 Novartis 109E - Long-term Treatment with ICL Alexis Thompson, MD
14 Novartis US19 - T2 Star Alexis Thompson, MD
15 Pulmonary Hypertension Prevalence Study (PHT) Robert Liem, MD
16 Pulmonary Hypertension-Hydroxyurea Pilot Trial (PHT-HU) Robert Liem, MD
17 Quality of Life (QOL) Robert Liem, MD
18 Silent Infarct Transfusion Trial in Sickle Cell Patients (SITT) Alexis Thompson, MD
19 sPLA2 Inhibitor in Sickle Cell Patients Alexis Thompson, MD
20 Sickle Cell Patients w Stroke and Transfusions Changing to Hydroxyurea (SWiTCH) Alexis Thompson, MD
21 Genetic Basis of Variability of Opioid Resp. in Ped Adoles Patients w/SCD A. Kyle Mack, MD
22 Tricuspid Regurgitant Jet Velocity in Children and Young Adults with Sickle Cell Disease Robert Liem, MD
23 The Clinical Pharmacology of Hydroxyurea in Pediatric Patient's with Sickle Cell Disease Robert Liem, MD
     
  Thalassemia Investigator
24 Novartis US04 - Evaluating Cardiac T2 Star in Beta Thalassemia Patients on ICL Alexis Thompson, MD
25 Rand. Trial Comparing DFO and L1 Effects on Cardiac Func in B Thal Adult Pts Alexis Thompson, MD
26 Thalassemia Data Collection (CDC) Alexis Thompson, MD
27 Thalassemia Longitudinal Cohort (TLC) Alexis Thompson, MD

Back to the top of the page